ON MOTION

ORDER

Warsaw Orthopedic, Inc. and Medtronic Sofamor Danek USA, Inc. (collectively Warsaw) move to dismiss the appeals for lack of appellate jurisdiction. NuVasive opposes. Warsaw replies.

Warsaw brought this suit against NuVa-sive for patent infringement of nine patents. NuVasive counterclaimed for infringement of three of its own patents. The district court directed the parties to select three patents each for the first phase of litigation (Phase I). A jury decided the issues of infringement, validity, and damages for the patents involved in Phase I, and the judge subsequently decided the inequitable conduct allegations against Warsaw. The district court entered a final judgment for Phase I pursuant to Fed. R.Civ.P. 54(b) despite the fact that prejudgment interest and the amount of ongoing royalties have not yet been decided by the court.

“A judgment is not final for Rule 54(b) purposes unless it is ‘an ultimate disposition of an individual claim entered in the course of a multiple claims action.’ ” W.L. Gore & Assocs., Inc. v. Int’l. Med. Prosthetics Research Assocs., Inc., 975 F.2d 858, 862-863 (citing Sears, Roebuck & Co. v. Mackey, 351 U.S. 427, 432, 76 S.Ct. 895, 100 L.Ed. 1297 (1956)). We agree with Warsaw that even assuming Rule 54(b) would give this court jurisdiction over a claim that is “final except for an accounting” within the meaning of 28 U.S.C. § 1292(c)(2), the case is not “final” because the district court has not yet determined ongoing royalties. An ongoing royalty is not the same as an accounting for damages. See Special Devices, Inc. v. OEA, Inc., 269 F.3d 1340, 1343 n. 2 (Fed.Cir. 2001) (“ ‘Accounting,’ as used in [§ 1292(c)(2) ], refers to infringement damages pursuant to 28 U.S.C. § 284.”).

Accordingly,

It Is Ordered That:

*883 (1) The motion is granted. The appeal is dismissed.

(2) Each side shall bear its own costs.